19h
Medexus Pharmaceuticals Inc (MEDXF) reports robust financial performance and prepares for significant product launches amidst regulatory challenges.
Q3 2025 Management View CEO Ken d'Entremont highlighted the successful FDA approval of GRAFAPEX, the branded name for treosulfan for injection in the U.S., which holds Orphan Drug Designation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback